NVIDIA and Lilly AI Lab All Set to Transform Drug Discovery
NVIDIA and Eli Lilly and Company have announced the creation of a new NVIDIA-Lilly AI lab, designed to apply artificial intelligence to some of...
Daiichi Sankyo Plans to Boost Its Antibody-Drug Conjugate
Daiichi Sankyo has recently made an announcement of its plans to invest almost 300 billion yen, which is equivalent to $1.9 billion, when it...
Samsung Biologics Acquires GSK’s Human Genome Sciences Site in U.S.
Samsung Biologics has agreed to acquire 100% of Human Genome Sciences from GSK, a move that secures the company’s first U.S.-based biologics manufacturing site...
Smart Factory Architectures Driving Efficiency in Pharma Plants
Smart factory technologies are transforming pharmaceutical manufacturing through the integration of automation, IoT sensors, and centralized control systems. This comprehensive guide explores how connected equipment and real-time monitoring enhance productivity, minimize downtime, and improve operational visibility while maintaining strict regulatory compliance in controlled manufacturing environments.
Cencora Continues Its Investment in Third-Party Logistics
Cencora, which is often termed as being one of the Big Three wholesalers, is continuing to go ahead and invest in its third-party logistics...
Lilly, IU Deepen Work on Clinical Trial Innovation Ecosystem
Eli Lilly and Company has entered a five-year collaboration with Indiana University that will provide up to $40 million to expand clinical trial access...
PLI Incentives Aim to Accelerate API Manufacturing in India
India's Department of Pharmaceuticals has launched a fresh application round under the Production Linked Incentive (PLI) Scheme targeting two high-priority active pharmaceutical ingredients, Meropenem,...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...